<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Sports Act. Living</journal-id>
<journal-title>Frontiers in Sports and Active Living</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Sports Act. Living</abbrev-journal-title>
<issn pub-type="epub">2624-9367</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fspor.2025.1601326</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sports and Active Living</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Preventing sarcopenia and promoting musculoskeletal health in middle-aged adults: the role of exercise and nutrition</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Ispoglou</surname><given-names>Theocharis</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1532137/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Norton</surname><given-names>Catherine</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1880404/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/></contrib>
<contrib contrib-type="author"><name><surname>McCullough</surname><given-names>Deaglan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2212188/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Carnegie School of Sport, Leeds Beckett University</institution>, <addr-line>Leeds</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Physical Education &#x0026; Sport Sciences, University of Limerick</institution>, <addr-line>Limerick</addr-line>, <country>Ireland</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited and Reviewed by:</bold> David Christopher Nieman, Appalachian State University, United States</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Theocharis Ispoglou <email>t.ispoglou@leedsbeckett.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>11</day><month>04</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>7</volume><elocation-id>1601326</elocation-id>
<history>
<date date-type="received"><day>27</day><month>03</month><year>2025</year></date>
<date date-type="accepted"><day>31</day><month>03</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Ispoglou, Norton and McCullough.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Ispoglou, Norton and McCullough</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<kwd-group>
<kwd>sarcopenia</kwd>
<kwd>resistance training</kwd>
<kwd>ultra-processed foods</kwd>
<kwd>gut-muscle axis</kwd>
<kwd>middle-aged adults</kwd>
<kwd>muscle protein synthesis</kwd>
<kwd>anabolic resistance</kwd>
<kwd>gender-specific barriers</kwd>
</kwd-group><counts>
<fig-count count="1"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="20"/><page-count count="4"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Sport and Exercise Nutrition</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Sports Act. Living" journal-id-type="nlm-ta" xlink:href="https://www.frontiersin.org/research-topics/56804/preventing-sarcopenia-and-promoting-musculoskeletal-health-in-middle-aged-adults-the-role-of-exercise-and-nutrition" ext-link-type="uri"><bold>Editorial on the Research Topic</bold> <article-title>Preventing sarcopenia and promoting musculoskeletal health in middle-aged adults: the role of exercise and nutrition</article-title></related-article>
<p>Sarcopenia, once considered an inevitable consequence of ageing, is now recognised as a complex syndrome influenced by lifestyle, disease, and acute physiological stress. As global life expectancy rises, its prevalence is increasing, placing a burden on healthcare systems (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>) due to its association with disability, frailty, and comorbidities (<xref ref-type="bibr" rid="B3">3</xref>). Prevalence estimates range from 0.2&#x0025; to 86.5&#x0025; depending on diagnostic criteria (<xref ref-type="bibr" rid="B4">4</xref>). While typically studied in older adults, evidence suggests an earlier onset, with rates between 8&#x0025; and 36&#x0025; in those younger than 60 years and between 10&#x0025; and 27&#x0025; in those aged 60 years and older (<xref ref-type="bibr" rid="B4">4</xref>). This variability partly reflects differences in classification, with the European Working Group on Sarcopenia in Older People (EWGSOP2) (<xref ref-type="bibr" rid="B5">5</xref>) defining primary sarcopenia (driven by ageing) and secondary sarcopenia (driven by disease, inactivity, or malnutrition), each of which poses distinct diagnostic challenges.</p>
<p>Acute sarcopenia, which refers to rapid muscle loss following illness or hospitalisation, has gained attention but remains inconsistently defined. Before Welch et al. (<xref ref-type="bibr" rid="B6">6</xref>) introduced the term &#x201C;acute sarcopenia&#x201D;, this phenomenon was typically defined as disease-related muscle wasting. EWGSOP2 (2019) (<xref ref-type="bibr" rid="B5">5</xref>) incorporated acute sarcopenia in its diagnostic framework, but its clinical application remains limited. A recent systematic review by Aldrich et al. (<xref ref-type="bibr" rid="B7">7</xref>) found that acute sarcopenia develops in 18&#x0025; of hospitalised patients, reaching 59&#x0025; in intensive care settings; however, current diagnostic criteria may underestimate muscle deterioration, impacting recovery, quality of life, and long-term health outcomes.</p>
<p>Despite ongoing efforts by multiple working groups (<xref ref-type="bibr" rid="B8">8</xref>), variability in definitions and diagnostic criteria hinders clinical recognition and intervention. Strengthening collaboration between organisations such as EWGSOP2 and the Global Leadership Initiative on Sarcopenia remains critical to advancing standardised diagnostic frameworks.</p>
<sec id="s1"><title>Early intervention: a critical window for prevention</title>
<p>While diagnostic precision is important, prevention must not be delayed, particularly in middle-aged adults, where early intervention can prevent muscle loss. Midlife is a key period for musculoskeletal health, with declines in neuromuscular efficiency (<xref ref-type="bibr" rid="B9">9</xref>), physical activity (<xref ref-type="bibr" rid="B10">10</xref>), hormonal alterations (e.g., oestrogen) (<xref ref-type="bibr" rid="B11">11</xref>), and poor dietary habits accelerating muscle loss (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Gender-specific barriers also influence the risk of sarcopenia, particularly in women during the perimenopausal phase (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Developing inclusive, accessible resistance training (RT) programmes tailored to women&#x0027;s needs &#x2013; addressing social, cultural, and practical barriers &#x2013; could improve long-term engagement.</p>
<p>A summary of the key intervention strategies and modifying factors for the prevention of sarcopenia in midlife is presented in <xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>. This Research Topic explored key lifestyle approaches, including nutrition, exercise, and gut-muscle interactions, offering solutions for sustaining musculoskeletal health through early, targeted intervention.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Lifestyle and behavioural strategies&#x2014;including exercise, nutrition, and social factors&#x2014;to support musculoskeletal health and prevent sarcopenia in midlife.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fspor-07-1601326-g001.tif"/>
</fig>
</sec>
<sec id="s2"><title>Ultra-processed foods (UPFs) and muscle deterioration</title>
<p>Diet is fundamental to muscle health, but modern dietary patterns are increasingly dominated by UPFs, which may accelerate muscle loss. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1280665">Kong et al.</ext-link> investigated the association between ultra-processed food (UPF) consumption and muscle health, revealing that higher UPF intake was significantly associated with low muscle mass in young to middle-aged adults. These findings reinforce the need to prioritise whole, nutrient-dense foods to reduce early muscle deterioration.</p>
<p>However, not all UPFs are inherently harmful. High-protein products, such as protein shakes and bars, fall into the UPF category but can support protein intake when consumed as part of a balanced diet. Alternatives, such as high-protein yoghurts containing probiotics, may also promote gut health. Future research should assess diet quality holistically, considering both benefits and risks when evaluating UPFs in muscle health strategies.</p>
<sec id="s2a"><title>The gut-muscle axis: a novel target for sarcopenia prevention</title>
<p>Emerging research highlights the gut-muscle axis as a key regulator of muscle health, linking gut microbiota to metabolism, inflammation, and function. Microbiome-targeted interventions may complement exercise and nutrition, offering therapeutic potential beyond sarcopenia prevention (<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1418778">Li et al.</ext-link> examined exercise-induced microbiome shifts and suggested that they might enhance muscle protein synthesis and metabolic resilience. Furthermore, diet critically influences gut health, with UPFs [associated with low muscle mass (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1418778">Li et al.</ext-link>)] shown to reduce microbial &#x03B1;-diversity and increase proinflammatory bacteria (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). By linking gut health to muscle function, new holistic health strategies may help mitigate muscle loss, metabolic disease, autoimmune disease, and chronic inflammation. While promising, causal mechanisms remain unclear, and future research must determine whether microbiome modulation &#x2013; through diet, probiotics, or exercise &#x2013; can offer viable therapeutic approaches for sarcopenia and broader health outcomes.</p>
</sec>
</sec>
<sec id="s3"><title>The protein paradox: why diet alone is insufficient</title>
<p>While protein remains crucial, diet alone is insufficient without exercise. Research shows that muscle protein synthesis declines with age, necessitating higher protein intake thresholds to stimulate an adequate anabolic response. Reviews highlight protein quality, timing, and distribution as key factors in maximising muscle preservation (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>).</p>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fspor.2024.1346637">Schalla et al.</ext-link> found that high-protein diets had minimal impact on muscle mass and strength in physically active middle-aged adults, reinforcing the need for an integrated approach combining diet and RT. This highlights a gap in current nutritional recommendations, where protein supplementation is often prioritised over exercise (i.e., RT), limiting its efficacy in the prevention of sarcopenia.</p>
</sec>
<sec id="s4"><title>Exercise as a primary prevention strategy</title>
<p>Of all interventions, exercise (i.e., RT) remains the most effective strategy for preventing muscle loss and function. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1484662">Li et al.</ext-link> conducted a network meta-analysis that identified RT as the most effective approach to counteracting sarcopenia, particularly in clinical populations.</p>
<p>Despite strong evidence supporting RT, participation remains low, with global participation rates of 18&#x0025;&#x2013;35&#x0025; in men and 14&#x0025;&#x2013;26&#x0025; in women (<xref ref-type="bibr" rid="B14">14</xref>). Common barriers, especially among midlife women, include perceived time constraints, lack of knowledge and education, exercise modality preferences, and social factors (<xref ref-type="bibr" rid="B15">15</xref>). Addressing these barriers through education, community-based programmes, and gender-inclusive training environments is crucial to improving adherence and maximising public health benefits.</p>
</sec>
<sec id="s5" sec-type="conclusions"><title>Conclusion</title>
<p>Despite the growing recognition of sarcopenia as a midlife health concern, prevention efforts remain fragmented. This collection highlights the urgent need for integrated, proactive strategies targeting modifiable lifestyle factors &#x2013; diet, resistance exercise, and gut health &#x2013; before significant muscle loss occurs.</p>
<p>Public health initiatives must prioritise early intervention with a coordinated effort to educate healthcare professionals, policymakers, and the public on the importance of exercise and nutrition for muscle health. While resistance exercise remains the most effective intervention, complementary nutritional strategies should focus on reducing UPF consumption, promoting gut health, and ensuring adequate, high-quality protein intake to maintain muscle.</p>
<p>Policymakers and healthcare systems must invest in accessible, evidence-based interventions tailored to midlife adults, embedding sarcopenia prevention within public health frameworks. Future research should enhance the accessibility, adherence, and long-term sustainability of interventions, making sarcopenia prevention a midlife priority rather than an afterthought.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="author-contributions"><title>Author contributions</title>
<p>TI: Writing &#x2013; original draft, Investigation, Conceptualization, Supervision, Writing &#x2013; review &#x0026; editing. CN: Conceptualization, Writing &#x2013; review &#x0026; editing, Investigation. DM: Conceptualization, Investigation, Writing &#x2013; review &#x0026; editing, Visualization.</p>
</sec>
<sec id="s7" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s8" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruy&#x00E8;re</surname><given-names>O</given-names></name><name><surname>Beaudart</surname><given-names>C</given-names></name><name><surname>Ethgen</surname><given-names>O</given-names></name><name><surname>Reginster</surname><given-names>JY</given-names></name><name><surname>Locquet</surname><given-names>M</given-names></name></person-group>. <article-title>The health economics burden of sarcopenia: a systematic review</article-title>. <source>Maturitas</source>. (<year>2019</year>) <volume>119</volume>:<fpage>61</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.maturitas.2018.11.003</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beaudart</surname><given-names>C</given-names></name><name><surname>Zaaria</surname><given-names>M</given-names></name><name><surname>Pasleau</surname><given-names>F</given-names></name><name><surname>Reginster</surname><given-names>JY</given-names></name><name><surname>Bruyere</surname><given-names>O</given-names></name></person-group>. <article-title>Health outcomes of sarcopenia: a systematic review and meta-analysis</article-title>. <source>PLoS One</source>. (<year>2017</year>) <volume>12</volume>:<fpage>e0169548</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0169548</pub-id><pub-id pub-id-type="pmid">28095426</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laskou</surname><given-names>F</given-names></name><name><surname>Fuggle</surname><given-names>NR</given-names></name><name><surname>Patel</surname><given-names>HP</given-names></name><name><surname>Jameson</surname><given-names>K</given-names></name><name><surname>Cooper</surname><given-names>C</given-names></name><name><surname>Dennison</surname><given-names>E</given-names></name></person-group>. <article-title>Associations of osteoporosis and sarcopenia with frailty and multimorbidity among participants of the hertfordshire cohort study</article-title>. <source>J Cachexia Sarcopenia Muscle</source>. (<year>2022</year>) <volume>13</volume>:<fpage>220</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/jcsm.12870</pub-id><pub-id pub-id-type="pmid">34873876</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petermann-Rocha</surname><given-names>F</given-names></name><name><surname>Balntzi</surname><given-names>V</given-names></name><name><surname>Gray</surname><given-names>SR</given-names></name><name><surname>Lara</surname><given-names>J</given-names></name><name><surname>Ho</surname><given-names>FK</given-names></name><name><surname>Pell</surname><given-names>JP</given-names></name><etal/></person-group> <article-title>Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis</article-title>. <source>J Cachexia Sarcopenia Muscle</source>. (<year>2022</year>) <volume>13</volume>:<fpage>86</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1002/jcsm.12783</pub-id><pub-id pub-id-type="pmid">34816624</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Jentoft</surname><given-names>AJ</given-names></name><name><surname>Bahat</surname><given-names>G</given-names></name><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Boirie</surname><given-names>Y</given-names></name><name><surname>Bruyere</surname><given-names>O</given-names></name><name><surname>Cederholm</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Sarcopenia: revised European consensus on definition and diagnosis</article-title>. <source>Age Ageing</source>. (<year>2019</year>) <volume>48</volume>:<fpage>16</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/ageing/afy169</pub-id><pub-id pub-id-type="pmid">30312372</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>C</given-names></name><name><surname>Hassan-Smith</surname><given-names>ZK</given-names></name><name><surname>Greig</surname><given-names>CA</given-names></name><name><surname>Lord</surname><given-names>JM</given-names></name><name><surname>Jackson</surname><given-names>TA</given-names></name></person-group>. <article-title>Acute sarcopenia secondary to hospitalisation - an emerging condition affecting older adults</article-title>. <source>Aging Dis</source>. (<year>2018</year>) <volume>9</volume>:<fpage>151</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.14336/ad.2017.0315</pub-id><pub-id pub-id-type="pmid">29392090</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aldrich</surname><given-names>L</given-names></name><name><surname>Ispoglou</surname><given-names>T</given-names></name><name><surname>Prokopidis</surname><given-names>K</given-names></name><name><surname>Alqallaf</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>O</given-names></name><name><surname>Stavropoulos-Kalinoglou</surname><given-names>A</given-names></name></person-group>. <article-title>Acute sarcopenia: systematic review and meta-analysis on its incidence and muscle parameter shifts during hospitalisation</article-title>. <source>J Cachexia Sarcopenia Muscle</source>. (<year>2025</year>) <volume>16</volume>:<fpage>e13662</fpage>. <pub-id pub-id-type="doi">10.1002/jcsm.13662</pub-id><pub-id pub-id-type="pmid">39690131</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirk</surname><given-names>B</given-names></name><name><surname>Cawthon</surname><given-names>PM</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>&#x00C1;vila-Funes</surname><given-names>JA</given-names></name><name><surname>Barazzoni</surname><given-names>R</given-names></name><name><surname>Bhasin</surname><given-names>S</given-names></name><etal/></person-group> <article-title>The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in sarcopenia (GLIS)</article-title>. <source>Age Ageing</source>. (<year>2024</year>) <volume>53</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1093/ageing/afae052</pub-id><pub-id pub-id-type="pmid">38520141</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>BM</given-names></name><name><surname>Lavin</surname><given-names>KM</given-names></name><name><surname>Many</surname><given-names>GM</given-names></name><name><surname>Thalacker-Mercer</surname><given-names>A</given-names></name><name><surname>Merritt</surname><given-names>EK</given-names></name><name><surname>Bickel</surname><given-names>CS</given-names></name><etal/></person-group> <article-title>Human neuromuscular aging: sex differences revealed at the myocellular level</article-title>. <source>Exp Gerontol</source>. (<year>2018</year>) <volume>106</volume>:<fpage>116</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2018.02.023</pub-id><pub-id pub-id-type="pmid">29481967</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramsey</surname><given-names>KA</given-names></name><name><surname>Rojer</surname><given-names>AGM</given-names></name><name><surname>D&#x2019;Andrea</surname><given-names>L</given-names></name><name><surname>Otten</surname><given-names>RHJ</given-names></name><name><surname>Heymans</surname><given-names>MW</given-names></name><name><surname>Trappenburg</surname><given-names>MC</given-names></name><etal/></person-group> <article-title>The association of objectively measured physical activity and sedentary behavior with skeletal muscle strength and muscle power in older adults: a systematic review and meta-analysis</article-title>. <source>Ageing Res Rev</source>. (<year>2021</year>) <volume>67</volume>:<fpage>101266</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2021.101266</pub-id><pub-id pub-id-type="pmid">33607291</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>BC</given-names></name><name><surname>Laakkonen</surname><given-names>EK</given-names></name><name><surname>Lowe</surname><given-names>DA</given-names></name></person-group>. <article-title>Aging of the musculoskeletal system: how the loss of estrogen impacts muscle strength</article-title>. <source>Bone</source>. (<year>2019</year>) <volume>123</volume>:<fpage>137</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2019.03.033</pub-id><pub-id pub-id-type="pmid">30930293</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname><given-names>R</given-names></name><name><surname>Nishita</surname><given-names>Y</given-names></name><name><surname>Tange</surname><given-names>C</given-names></name><name><surname>Tomida</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Age-related 12-year changes in dietary diversity and food intakes among community-dwelling Japanese aged 40 to 79 years</article-title>. <source>J Nutr Health Aging</source>. (<year>2018</year>) <volume>22</volume>:<fpage>594</fpage>&#x2013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1007/s12603-018-0999-3</pub-id><pub-id pub-id-type="pmid">29717759</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rippin</surname><given-names>HL</given-names></name><name><surname>Hutchinson</surname><given-names>J</given-names></name><name><surname>Jewell</surname><given-names>J</given-names></name><name><surname>Breda</surname><given-names>JJ</given-names></name><name><surname>Cade</surname><given-names>JE</given-names></name></person-group>. <article-title>Adult nutrient intakes from current national dietary surveys of European populations</article-title>. <source>Nutrients</source>. (<year>2017</year>) <volume>9</volume>:<fpage>1288</fpage>. <pub-id pub-id-type="doi">10.3390/nu9121288</pub-id><pub-id pub-id-type="pmid">29186935</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nuzzo</surname><given-names>JL</given-names></name></person-group>. <article-title>Sex difference in participation in muscle-strengthening activities</article-title>. <source>J Lifestyle Med</source>. (<year>2020</year>) <volume>10</volume>:<fpage>110</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.15280/jlm.2020.10.2.110</pub-id><pub-id pub-id-type="pmid">32995338</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stimson</surname><given-names>AM</given-names></name><name><surname>Anderson</surname><given-names>C</given-names></name><name><surname>Holt</surname><given-names>A-M</given-names></name><name><surname>Henderson</surname><given-names>AJ</given-names></name></person-group>. <article-title>Why don&#x0027;t women engage in muscle strength exercise? An integrative review</article-title>. <source>Health Promot J Austr</source>. (<year>2024</year>) <volume>35</volume>:<fpage>911</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1002/hpja.857</pub-id><pub-id pub-id-type="pmid">38566279</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>DJ</given-names></name><name><surname>Wu</surname><given-names>SSX</given-names></name><name><surname>Cooke</surname><given-names>MB</given-names></name></person-group>. <article-title>The relationship between gut microbiota, muscle mass and physical function in older individuals: a systematic review</article-title>. <source>Nutrients</source>. (<year>2025</year>) <volume>17</volume>:<fpage>81</fpage>. <pub-id pub-id-type="doi">10.3390/nu17010081</pub-id><pub-id pub-id-type="pmid">39796514</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rondinella</surname><given-names>D</given-names></name><name><surname>Raoul</surname><given-names>PC</given-names></name><name><surname>Valeriani</surname><given-names>E</given-names></name><name><surname>Venturini</surname><given-names>I</given-names></name><name><surname>Cintoni</surname><given-names>M</given-names></name><name><surname>Severino</surname><given-names>A</given-names></name><etal/></person-group> <article-title>The detrimental impact of ultra-processed foods on the human gut microbiome and gut barrier</article-title>. <source>Nutrients</source>. (<year>2025</year>) <volume>17</volume>:<fpage>859</fpage>. <pub-id pub-id-type="doi">10.3390/nu17050859</pub-id><pub-id pub-id-type="pmid">40077728</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuevas-Sierra</surname><given-names>A</given-names></name><name><surname>Milagro</surname><given-names>FI</given-names></name><name><surname>Aranaz</surname><given-names>P</given-names></name><name><surname>Mart&#x00ED;nez</surname><given-names>JA</given-names></name><name><surname>Riezu-Boj</surname><given-names>JI</given-names></name></person-group>. <article-title>Gut microbiota differences according to ultra-processed food consumption in a Spanish population</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.3390/nu13082710</pub-id><pub-id pub-id-type="pmid">34444870</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ispoglou</surname><given-names>T</given-names></name><name><surname>Wilson</surname><given-names>O</given-names></name><name><surname>McCullough</surname><given-names>D</given-names></name><name><surname>Aldrich</surname><given-names>L</given-names></name><name><surname>Ferentinos</surname><given-names>P</given-names></name><name><surname>Lyall</surname><given-names>G</given-names></name><etal/></person-group> <article-title>A narrative review of non-pharmacological strategies for managing sarcopenia in older adults with cardiovascular and metabolic diseases</article-title>. <source>Biology (Basel)</source>. (<year>2023</year>) <volume>12</volume>:<fpage>892</fpage>. <pub-id pub-id-type="doi">10.3390/biology12070892</pub-id><pub-id pub-id-type="pmid">37508325</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witard</surname><given-names>OC</given-names></name><name><surname>McGlory</surname><given-names>C</given-names></name><name><surname>Hamilton</surname><given-names>DL</given-names></name><name><surname>Phillips</surname><given-names>SM</given-names></name></person-group>. <article-title>Growing older with health and vitality: a nexus of physical activity, exercise and nutrition</article-title>. <source>Biogerontology</source>. (<year>2016</year>) <volume>17</volume>:<fpage>529</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-016-9637-9</pub-id><pub-id pub-id-type="pmid">26878863</pub-id></citation></ref></ref-list>
</back>
</article>